ET(B) receptor and nitric oxide synthase blockade induce BQ-123- sensitive pressor effects in the rabbit

Hypertension

Volumn 30, Issue 5, 1997, Pages 1204-1209

  Gratton, Jean Philippe ^a   Cournoyer, Ghislain ^a   Löffler, Bernd Michael ^b   Sirois, Pierre ^a   D'Orléans Juste, Pedro ^a  

^a UNIVERSITÉ DE SHERBROOKE   (Canada)

^b F HOFFMANN LA ROCHE LTD   (Switzerland)

Author keywords

Arterial pressure; Endothelin; Endothelin converting enzyme; Endothelin 1; Nitric oxide; Rabbits; Receptors

Indexed keywords

BIG ENDOTHELIN 1; CYCLO(DEXTRO TRYPTOPHYL DEXTRO ASPARTYLPROLYL DEXTRO VALYLLEUCYL); ENDOTHELIN A RECEPTOR ANTAGONIST; ENDOTHELIN B RECEPTOR; ENDOTHELIN B RECEPTOR ANTAGONIST; ENDOTHELIN CONVERTING ENZYME; N (2,6 DIMETHYLPIPERIDINOCARBONYL) 4 METHYLLEUCYL DEXTRO (1 METHOXYCARBONYLTRYPTOPHANYL) DEXTRO NORLEUCINE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE INHIBITOR; PHOSPHORAMIDON;

ARTICLE; CONTROLLED STUDY; ENZYME INHIBITION; FEMALE; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; PRESSOR RESPONSE; PRIORITY JOURNAL; RABBIT; RECEPTOR BLOCKING; VASOCONSTRICTION;

EID: 0030725503     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.30.5.1204     Document Type: Article

References (29)

1. de Nucci G, Thomas R, D'Orléans-Juste P, Antunes E, Walder C, Warner TD, Vane JR. Pressor effects of circulating endothelin are limited by its removal in the pulmonary circulation and by the release of prostacyclin and endothelium-derived relaxing factor. Proc Natl Acad Sci U S A. 1988;85:9797-9800.
2. B receptor antagonist, BQ-788. Br J Pharmacol. 1994;113:1257-1262.
3. Boulanger CM, Luscher TF. Diffrerential effect of cyclic GMP on the release of endothelin-1 from cultured endothelial cells and intact porcine aorta. J Cardiovasc Pharmacol. 1991;17:S264-S266.
4. Clozel M, Breu V, Gray GA, Kalina B, Löffler BM, Burri K, Cassal JM, Hirth G, Muller M, Neidhart W, Ramuz H. Pharmacological characterization of bosentan, a new potent orally active non peptide endothelin receptor antagonist. J Pharmacol Exp Ther. 1994;270:228-235.
5. Chen SJ, Chen TY, Meng QC, Durand J, Dicarlo VS, Oparil S. Endothelin-receptor antagonist bosentan prevents and reverses hypoxic pulmonary hypertension in rats. J Appl Physiol. 1995;79: 2122-2131.
6. Giaid A, Yanagisawa M, Langleben D, Michel RP, Levy R, Shennib H, Kimura S, Masaki T, Duguid WP, Stewart DJ. Expression of endothelin-1 in the lungs of patients with pulmonary hypertension. N Engl J Med. 1993;328:1732-1739.
7. Kiowski W, Sutsch G, Hunziker P, Muller P, Kim J, Oechslin E, Schmitt R, Jones R, Bertel O. Evidence for endothelin-1-mediated vasoconstriction in severe chronic heart failure. Lancet. 1995;346:732-736.
8. Warner TD, Mitchell JA, de Nucci G, Vane JR. Endothelin-1 and endothelin-3 release EDRF from isolated perfused arterial vessels of the rat and rabbit. J Cardiovasc Pharmacol. 1989;13:S85-S88.
9. B-like receptors. Biochem Biophys Res Commun. 1992;184:100-106.
10. McMurdo L, Corder R, Thimermann C, Vane JR. Incomplete inhibition of the pressor effects of endothelin-1 and related peptides in the anaesthetized rat with BQ-123 provides evidence for more than one vasoconstrictor receptor. Br J Pharmacol. 1993;108:557-561.
11. Haynes WG, Webb DJ. Endothelium-dependent modulation of responses to endothelin-1 in human veins. Clin Sci. 1993;84:427-433.
12. B receptor antagonists, BQ-928 and 238, in the carotid and pulmonary arteries and the perfused kidney of the rabbit. Br J Pharmacol. 1997;120:319-325.
13. Allcock GH, Warner TD, Vane JR. Roles of endothelin receptors in the regional and systemic vascular responses to ET-1 in the anaesthetized ganglion-blocked rat: use of selective antagonists. Br J Pharmacol. 1995;116:2482-2486.
14. B receptor antagonist Ro 46-8443. FEBS Lett. 1996;383:42-45.
15. Löffler BM, Breu V, Clozel M. Effect of different endothelin receptor antagonists and of the novel non-peptide antagonist Ro 46-2005 on endothelin levels in rat plasma. FEBS Lett. 1993;333:108-110.
16. King AJ, Brenner BM, Anderson S. Endothelin: a potent renal and systemic vasoconstrictor peptide. Am J Physiol. 1989;256:F1051-F1058.
17. Haynes WG, Ferro CJ, O'Kane KPJ, Somerville D, Lomax CC, Webb DJ, Systemic endothelin receptor blockade decreases peripheral vascular resistance and blood pressure in humans. Circulation. 1996;93:1860-1870.
18. Love MP, Ferro CJ, Haynes WG, Webb DJ, McMurray JJ. Selective or non-selective endothelin receptor blockade in chronic heart failure. Circulation. 1996;94(suppl 1):74. Abstract.
19. Haynes WG, Webb DJ. Contribution of endogenous generation of endothelin-1 to basal vascular tone. Lancet. 1994;344:852-854.
20. Löffler BM, Jacot-Guillarmond H, Maire JP. Concentrations and ratios of immunoreactive big-endothelin-1 and endothelin-1 in human, rat and rabbit plasma. Biochem Int. 1992;27:755-761.
21. B receptors in rats. Biochem Biophys Res Commun. 1994;199:1461-1465.
22. B receptors. J Appl Physiol. 1996;81:1510-1515.
23. Ishikawa K, Ihara M, Noguchi K, Mase T, Mino N, Saeki T, Fukuroda T, Fukami T, Ozaki S, Nagase T, Nishikibe M, Yano M. Biochemical and pharmacological profile of a potent and selective endothelin B-receptor antagonist, BQ-788. Proc Natl Acad Sci U S A. 1994;91:4892-4896.
24. Lerman A, Hildebrand FL, Aarhus LL, Burnett JC. Endothelin has biological actions at pathophysiological concentrations. Circulation. 1991;83:1808-1814.
25. Richard V, Hogie M, Clozel M, Löffler BM, Thuillez C. In vivo evidence of an endothelin-induced vasopressor tone after inhibition of nitric oxide synthesis in rats. Circulation. 1995;91:771-775.
26. Banting JD, Friberg P, Adams MA. Acute hypertension after nitric oxide synthase inhibition is mediated primarily by increased endothelin vasoconstriction. J Hypertens. 1999;14:975-981.
27. Plumpton C, Ferro CJ, Haynes WG, Webb DJ, Davenport AP. The increase in human plasma immunoreactive endothelin but not big endothelin-1 or its C-terminal fragment induced by systemic administration of the endothelin antagonist TAK-044. Br J Pharmacol. 1996;119:311-314.
28. Xu D, Emoto N, Giaid A, Slaughter C, Kaw S, deWit D, Yanagisawa M. ECE-I: a membrane-bound metalloprotease that catalyzes the proteolytic activation of big endothelin-1. Cell. 1994; 78:473-485.
29. Stockenhuber F, Gottsauner-Wolf M, Marosi L, Liebisch B, Kurz RW, Balcke P. Plasma levels of endothelin in chronic renal failure and after renal transplantation: impact on hypertension and cyclosporin A-associated nephrotoxicity. Clin Sci. 1992;82:255-258.